➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Moodys
Mallinckrodt
McKesson
Medtronic

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

INDOCYANINE GREEN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Indocyanine Green, and what generic alternatives are available?

Indocyanine Green is a drug marketed by Diagnostic Green and is included in one NDA.

The generic ingredient in INDOCYANINE GREEN is indocyanine green. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the indocyanine green profile page.

US ANDA Litigation and Generic Entry Outlook for Indocyanine Green

A generic version of INDOCYANINE GREEN was approved as indocyanine green by DIAGNOSTIC GREEN on November 21st, 2007.

  Start Trial

Drug patent expirations by year for INDOCYANINE GREEN
Recent Clinical Trials for INDOCYANINE GREEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NYU Langone HealthPhase 1
Fujian Medical UniversityN/A
Sun Yat-sen UniversityPhase 1

See all INDOCYANINE GREEN clinical trials

Medical Subject Heading (MeSH) Categories for INDOCYANINE GREEN

US Patents and Regulatory Information for INDOCYANINE GREEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Diagnostic Green INDOCYANINE GREEN indocyanine green INJECTABLE;INJECTION 040811-001 Nov 21, 2007 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Baxter
McKinsey
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.